These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 12526978)
1. A new treatment for HCV-ulcerative colitis comorbidity intolerant to INF-alpha. Sawada K; Ohnishi K; Fukunaga K; Shimoyama T Am J Gastroenterol; 2003 Jan; 98(1):228-9. PubMed ID: 12526978 [No Abstract] [Full Text] [Related]
2. [Multiple extrahepatic manifestations in a patient with chronic hepatitis C treated with interferon-alfa]. Napoli N; Tortorella C; Deramo MT; Antonaci A; Parisi CV; Antonaci S Recenti Prog Med; 2004 Nov; 95(11):525-8. PubMed ID: 15598090 [TBL] [Abstract][Full Text] [Related]
3. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study. Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058 [TBL] [Abstract][Full Text] [Related]
4. Granulocytapheresis in the treatment of patients with active ulcerative colitis. Bresci G Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):639-43. PubMed ID: 19072341 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study. Sakata Y; Iwakiri R; Amemori S; Yamaguchi K; Fujise T; Otani H; Shimoda R; Tsunada S; Sakata H; Ikeda Y; Ando T; Nakafusa Y; Fujimoto K Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):629-33. PubMed ID: 18679064 [TBL] [Abstract][Full Text] [Related]
6. Exacerbation of Psychogenic Movement Disorder by Interferon{alpha} Treatment of Hepatitis C. Mundt AP; Sarkar R; Winter C; Schaefer M; Ströhle A Psychosomatics; 2007; 48(1):86-7. PubMed ID: 17209157 [No Abstract] [Full Text] [Related]
7. Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules? Schaefer M; Heinz A; Backmund M Addiction; 2004 Sep; 99(9):1167-75. PubMed ID: 15317637 [TBL] [Abstract][Full Text] [Related]
8. [Therapeutic difficulties in a patient with ulcerative colitis and concomitant HBV and HCV infection]. Sikorska-Wiśniewska G; Liberek A; Bako W; Góra-Gebka M Med Wieku Rozwoj; 2004; 8(2 Pt 2):377-82. PubMed ID: 15849395 [TBL] [Abstract][Full Text] [Related]
9. [Management and treatment of ulcerative colitis. 2. Cytapheresis conducted on ulcerative colitis]. Nihon Naika Gakkai Zasshi; 2009 Jan; 98(1):61-7. PubMed ID: 19334357 [No Abstract] [Full Text] [Related]
10. Natural leukocyte interferon alfa for the treatment of chronic viral hepatitis in heart transplant recipients. Fagiuoli S; Pevere S; Minniti F; Livi U; Caforio AL; Naccarato R; Chiaramonte M Transplantation; 2003 Apr; 75(7):982-6. PubMed ID: 12698084 [TBL] [Abstract][Full Text] [Related]
11. A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin. Yalcin K; Degertekin H; Yildiz F; Kilinc N J Gastroenterol; 2003; 38(8):796-800. PubMed ID: 14505137 [TBL] [Abstract][Full Text] [Related]
12. Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study. Yamamoto T; Umegae S; Kitagawa T; Yasuda Y; Yamada Y; Takahashi D; Mukumoto M; Nishimura N; Yasue K; Matsumoto K Aliment Pharmacol Ther; 2004 Oct; 20(7):783-92. PubMed ID: 15379839 [TBL] [Abstract][Full Text] [Related]
13. Association of TLR7 single nucleotide polymorphisms with chronic HCV-infection and response to interferon-a-based therapy. Schott E; Witt H; Neumann K; Bergk A; Halangk J; Weich V; Müller T; Puhl G; Wiedenmann B; Berg T J Viral Hepat; 2008 Jan; 15(1):71-8. PubMed ID: 18088248 [TBL] [Abstract][Full Text] [Related]
14. [Interferon alpha-associated retinopathy in patients with chronic hepatitis C]. Schmidt S; Pleyer U Klin Monbl Augenheilkd; 2005 Nov; 222(11):915-8. PubMed ID: 16308826 [TBL] [Abstract][Full Text] [Related]
16. Rheumatological manifestations of hepatitis C: incidence in a rheumatology and non-rheumatology setting and the effect of methotrexate and interferon. Nissen MJ; Fontanges E; Allam Y; Zoulim F; Trépo C; Miossec P Rheumatology (Oxford); 2005 Aug; 44(8):1016-20. PubMed ID: 15855185 [TBL] [Abstract][Full Text] [Related]
17. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy. Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649 [TBL] [Abstract][Full Text] [Related]
18. [Thrombocytopenia in HCV infection. Natural interferon as an alternative therapy]. Krzowska-Firych J; Modrzewska R; Kiciak SG Przegl Epidemiol; 2007; 61(4):771-6. PubMed ID: 18572510 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin. Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081 [TBL] [Abstract][Full Text] [Related]
20. Cytapheresis therapy for ulcerative colitis in three pediatric patients. Mori K; Yoshihara T; Ando T; Tsubai S; Matsuo S; Aoyama M; Yamamoto T; Kawase Y J Pediatr Gastroenterol Nutr; 2004 Nov; 39(5):549-51. PubMed ID: 15572898 [No Abstract] [Full Text] [Related] [Next] [New Search]